Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
Current Concepts in the Imaging of Uterine Sarcomas
Radiol Clin North Am. 2023 Jul;61(4):627-638. doi: 10.1016/j.rcl.2023.02.008. Epub 2023 Apr 3.ABSTRACTUterine sarcomas are a group of rare uterine tumors comprised of multiple subtypes with different histologic characteristics, prognoses, and imaging appearances. Identification of uterine sarcomas and their differentiation from benign uterine disease on imaging is of critical importance for treatment planning to guide appropriate management and optimize patient outcomes. Herein, we review the spectrum of uterine sarcomas with a focus on the classification of primary sarcoma subtypes and presenting the typical MR imaging ap...
Source: Radiologic Clinics of North America - May 11, 2023 Category: Radiology Authors: Robert Petrocelli Nicole Hindman Caroline Reinhold Source Type: research
Challenges in the care of Ewing ’s sarcoma in a Jehovah’s Witness patient
We present the case of a 34-year-old Colombian woman, Jehovah’s Witness, diagnosed with Ewing’s sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.PMID:37167460 | DOI:10.7705/biomedica.6720 (Source: Biomedica : Revista del Instituto Nacional de Salud)
Source: Biomedica : Revista del Instituto Nacional de Salud - May 11, 2023 Category: International Medicine & Public Health Authors: Carlos Julio Vargas-Potes Diana Marcela Mendoza-Urbano Luis Gabriel Parra-Lara Ángela R Zambrano Source Type: research
